Myopathy due to other toxic agents

G6_MYOPTOX

muscular disease: Acquired, familial, and congenital disorders of skeletal muscle and smooth muscle.

Endpoint definition

FinnGen phenotype data

392423 individuals

diagram downward connector

Apply sex-specific rule None

392423

diagram downward connector

Check conditions None

392423

diagram downward connector
diagram bullet

Check pre-conditions, main-only, mode, registry filters

Hospital Discharge: ICD-10 G72.2
Hospital discharge: ICD-9 3594A
Cause of death: ICD-10 G72.2
Cause of death: ICD-9 3594A

2 out of 7 registries used, show all original rules.

18

diagram downward connector

Check minimum number of events None

18

diagram downward connector

Include endpoints None

18

diagram downward connector
diagram bullet diagram downward connector

Remove individuals based on genotype QC

18

diagram downward connector
G6_MYOPTOX

Control definitions

Control exclude G6_MYONEU

Extra metadata

Level in the ICD hierarchy 3
First used in FinnGen datafreeze DF2
Parent code in ICD-10 G72
Name in latin Myopathia toxica (non alcoholica)

Summary Statistics

Key figures

All Female Male
Number of individuals 18 7 11
Unadjusted prevalence (%) 0.00 0.00 0.01
Mean age at first event (years) 58.60 62.03 56.42

Mortality

Follow-up Absolute risk HR [95% CI] p N
1998–2019 - - - -
15 years - - - -
5 years - - - -
1 year - - - -

Age distribution of first events

Year distribution of first events

Cumulative Incidence

Correlations

Index endpoint: G6_MYOPTOX – Myopathy due to other toxic agents
GWS hits:

Survival analyses between endpoints

Not a core endpoint, no data to show.

Drugs most likely to be purchased after Myopathy due to other toxic agents

Endpoint not on priority list, no data to show.